The Impact of COVID-19 Vaccination on Bulgarian Patients with Uncomplicated Type 2 Diabetes Mellitus as the Only Chronic Condition

1Parenica J, Benesova K, Radvan M, et al. COVID-19 vaccine booster significantly decreases the risk of intensive care unit hospitalization in heart failure patients during the Omicron variant wave: A population-based study. Front Cardiovasc Med. 2022, 9:998842. doi: 10.3389/fcvm.2022.998842Search in Google Scholar

2Khan QJ, Bivona CR, Martin GA, et al. Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant. JAMA Oncology. 2022;8(7):1053-8.Search in Google Scholar

3Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015 Oct 10;6(13):1246-58. Search in Google Scholar

4Lee A, Wong SY, Chai LYA, et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022 Mar 2;376:e068632. Search in Google Scholar

5Boroumand AB, Forouhi M, Karimi F, et al. Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review. Frontiers Immunol. 2022;13:940357.Search in Google Scholar

6Frydrych LM, Bian G, O’Lone DE, et al. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leuk Biol. 2018 Sep;104(3):525-34. Search in Google Scholar

7Liu S, Jiang C, Liu Y, et al. The effectiveness of COVID-19 vaccination against all-cause mortality in patients with type 2 diabetes mellitus: The observation during the initial period of the cancellation of the "Dynamic Zero Policy" in mainland China. Diabetes Res Clin Pract. 2023 Jun;200:110694.Search in Google Scholar

8Fedeli U, Amidei CB, Casotto V, et al. Excess diabetes-related deaths: The role of comorbidities through different phases of the COVID-19 pandemic. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2023 May 30.Search in Google Scholar

9Sharma P, Behl T, Sharma N, et al. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality. Biomed Pharmacother. 2022 2022/07/01/;151:113089.Search in Google Scholar

10Geca T, Wojtowicz K, Guzik P, Gora T. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention. Int J Environ Res Pub Health. 2022 May 27;19(11).Search in Google Scholar

11Hurissi E, Alameer M, Ageeli F, et al. The Association between SARS-CoV-2 Infection and Diabetic Ketoacidosis in Patients with New-Onset Diabetes: A Retrospective Study from a Diabetic Center in Saudi Arabia. Pediatric Reports. 2022;14(4):519-27. doi:10.3390/pediatric14040060.Search in Google Scholar

12Khunti K, Aroda VR, Aschner P, et al. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. The Lancet Diabetes & Endocrinology. 2022 Dec;10(12):890-900. Search in Google Scholar

13Omboni S, Padwal RS, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connected Health. 2022 Jan 4;1:7-35.Search in Google Scholar

14Bianchi FP, Stefanizzi P, Martinelli A, et al. COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis. Vaccine. 2023 Feb 10;41(7):1303-9.Search in Google Scholar